A 52-year-old male with HCC in the NCR group. A and B, The tumor with a maximum diameter of 3.0 cm had irregular margins (white arrow) on preoperative MR imaging. C and D, One week after TACE/HIFU treatment, the tumor had no enhancement in the arterial phase or the portal venous phase. E and F, Five months after TACE/HIFU treatment, enhanced tissue around the tumor (white arrow) demonstrated the recurrence of HCC.